Recombinant multi-species NISCH/IR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NISCH/IR1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a nonadrenergic imidazoline-1 receptor protein that localizes to the cytosol and anchors to the inner layer of the plasma membrane. The orthologous mouse protein has been shown to influence cytoskeletal organization and cell migration by binding to alpha-5-beta-1 integrin. In humans, this protein has been shown to bind to the adapter insulin receptor substrate 4 (IRS4) to mediate translocation of alpha-5 integrin from the cell membrane to endosomes. Expression of this protein was reduced in human breast cancers while its overexpression reduced tumor growth and metastasis; possibly by limiting the expression of alpha-5 integrin. In human cardiac tissue, this gene was found to affect cell growth and death while in neural tissue it affected neuronal growth and differentiation. Alternative splicing results in multiple transcript variants encoding differerent isoforms. Some isoforms lack the expected C-terminal domains of a functional imidazoline receptor. [provided by RefSeq, Jan 2013]
The Alternative Names of target: NISCH, IR1,Nischarin,Imidazoline receptor 1 (I-1, IR1), Imidazoline receptor antisera-selected protein (hIRAS), Imidazoline-1 receptor (I1R), Imidazoline-1 receptor candidate protein (I-1 receptor candidate protein, I1R candidate protein),I-1,IR1,IRAS,hIRAS
Go
to NISCH/IR1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T78943-Ab-1/ GM-Tg-hg-T78943-Ab-2 | Human NISCH/IR1 protein | Human |
GM-Tg-rg-T78943-Ab-1/ GM-Tg-rg-T78943-Ab-2 | Rat NISCH/IR1 protein | Rat |
GM-Tg-mg-T78943-Ab-1/ GM-Tg-mg-T78943-Ab-2 | Mouse NISCH/IR1 protein | Mouse |
GM-Tg-cynog-T78943-Ab-1/ GM-Tg-cynog-T78943-Ab-2 | Cynomolgus/Rhesus macaque NISCH/IR1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T78943-Ab-1/ GM-Tg-felg-T78943-Ab-2 | Feline NISCH/IR1 protein | Feline |
GM-Tg-cang-T78943-Ab-1/ GM-Tg-cang-T78943-Ab-2 | Canine NISCH/IR1 protein | Canine |
GM-Tg-bovg-T78943-Ab-1/ GM-Tg-bovg-T78943-Ab-2 | Bovine NISCH/IR1 protein | Bovine |
GM-Tg-equg-T78943-Ab-1/ GM-Tg-equg-T78943-Ab-2 | Equine NISCH/IR1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. |
GM-Tg-hg-T78943-Ab-1/ GM-Tg-hg-T78943-Ab-2;
GM-Tg-rg-T78943-Ab-1/ GM-Tg-rg-T78943-Ab-2;
GM-Tg-mg-T78943-Ab-1/ GM-Tg-mg-T78943-Ab-2; GM-Tg-cynog-T78943-Ab-1/ GM-Tg-cynog-T78943-Ab-2; GM-Tg-felg-T78943-Ab-1/ GM-Tg-felg-T78943-Ab-2; GM-Tg-cang-T78943-Ab-1/ GM-Tg-cang-T78943-Ab-2; GM-Tg-bovg-T78943-Ab-1/ GM-Tg-bovg-T78943-Ab-2; GM-Tg-equg-T78943-Ab-1/ GM-Tg-equg-T78943-Ab-2 |
Products Name | NISCH/IR1 protein |
Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
Target Name | NISCH/IR1 |
Protein Sub-location | Introcelluar Protein |
Isotypes | Recombinant protein |
Expression platform | Mammalian cell |
Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
Tag | His |
Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NISCH/IR1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab
GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.